Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

92 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
High expression of cathepsin B and plasminogen activator inhibitor type-1 are strong predictors of survival in glioblastomas.
Colin C, Voutsinos-Porche B, Nanni I, Fina F, Metellus P, Intagliata D, Baeza N, Bouvier C, Delfino C, Loundou A, Chinot O, Lah T, Kos J, Martin PM, Ouafik L, Figarella-Branger D. Colin C, et al. Among authors: delfino c. Acta Neuropathol. 2009 Dec;118(6):745-54. doi: 10.1007/s00401-009-0592-2. Epub 2009 Sep 23. Acta Neuropathol. 2009. PMID: 19774387
Prognostic impact of CD133 mRNA expression in 48 glioblastoma patients treated with concomitant radiochemotherapy: a prospective patient cohort at a single institution.
Metellus P, Nanni-Metellus I, Delfino C, Colin C, Tchogandjian A, Coulibaly B, Fina F, Loundou A, Barrie M, Chinot O, Ouafik L, Figarella-Branger D. Metellus P, et al. Among authors: delfino c. Ann Surg Oncol. 2011 Oct;18(10):2937-45. doi: 10.1245/s10434-011-1703-6. Epub 2011 Apr 9. Ann Surg Oncol. 2011. PMID: 21479688 Clinical Trial.
Differential expression of miR200a-3p and miR21 in grade II-III and grade IV gliomas: evidence that miR200a-3p is regulated by O⁶-methylguanine methyltransferase and promotes temozolomide responsiveness.
Berthois Y, Delfino C, Metellus P, Fina F, Nanni-Metellus I, Al Aswy H, Pirisi V, Ouafik L, Boudouresque F. Berthois Y, et al. Among authors: delfino c. Cancer Biol Ther. 2014 Jul;15(7):938-50. doi: 10.4161/cbt.28920. Epub 2014 Apr 22. Cancer Biol Ther. 2014. PMID: 24755707 Free PMC article.
Adrenomedullin blockade induces regression of tumor neovessels through interference with vascular endothelial-cadherin signalling.
Khalfaoui-Bendriss G, Dussault N, Fernandez-Sauze S, Berenguer-Daizé C, Sigaud R, Delfino C, Cayol M, Metellus P, Chinot O, Mabrouk K, Martin PM, Ouafik L. Khalfaoui-Bendriss G, et al. Among authors: delfino c. Oncotarget. 2015 Apr 10;6(10):7536-53. doi: 10.18632/oncotarget.3167. Oncotarget. 2015. PMID: 25924235 Free PMC article.
Targeting adrenomedullin receptors with systemic delivery of neutralizing antibodies inhibits tumor angiogenesis and suppresses growth of human tumor xenografts in mice.
Kaafarani I, Fernandez-Sauze S, Berenguer C, Chinot O, Delfino C, Dussert C, Metellus P, Boudouresque F, Mabrouk K, Grisoli F, Figarella-Branger D, Martin PM, Ouafik L. Kaafarani I, et al. Among authors: delfino c. FASEB J. 2009 Oct;23(10):3424-35. doi: 10.1096/fj.08-127852. Epub 2009 Jun 22. FASEB J. 2009. PMID: 19546305
Expression and role of adrenomedullin in renal tumors and value of its mRNA levels as prognostic factor in clear-cell renal carcinoma.
Deville JL, Bartoli C, Berenguer C, Fernandez-Sauze S, Kaafarani I, Delfino C, Fina F, Salas S, Muracciole X, Mancini J, Lechevallier E, Martin PM, Figarella-Branger D, Ouafik L, Daniel L. Deville JL, et al. Among authors: delfino c. Int J Cancer. 2009 Nov 15;125(10):2307-15. doi: 10.1002/ijc.24568. Int J Cancer. 2009. PMID: 19610056 Free article.
92 results